Balapal Neha, Ankem Amala, Shyamsundar Saishravan, He Shuhan
City University of New York School of Medicine, New York, NY, United States.
Lab of Computer Science, Massachusetts General Hospital, Boston, MA, United States.
JMIR Med Educ. 2022 Jul 18;8(3):e37081. doi: 10.2196/37081.
Opioid use disorder (OUD) is a major public health concern in the United States. The opioid crisis has taken hundreds of thousands of lives in the past 20 years, and it is predicted to take millions more. With the rising death tolls, it is essential that health care providers are able to use proper tools to treat OUD efficiently and effectively through medication-assisted treatment (MAT), particularly buprenorphine. Despite changes to buprenorphine regulations making it more accessible, clinicians have been slow to use buprenorphine to treat OUD. We believe that training student clinicians in evidence-based MAT and buprenorphine practices will address the training and competence barriers that hinder clinicians from prescribing buprenorphine to treat OUD. Students are in an ideal position to receive and benefit from this training and influence the medical community to better treat OUD.
阿片类药物使用障碍（OUD）是美国主要的公共卫生问题。在过去20年里，阿片类药物危机已夺走数十万人的生命，预计还会夺走数百万人的生命。随着死亡人数的不断上升，医疗保健提供者能够通过药物辅助治疗（MAT），特别是丁丙诺啡，使用适当的工具高效且有效地治疗OUD至关重要。尽管丁丙诺啡法规的变化使其更容易获得，但临床医生在使用丁丙诺啡治疗OUD方面一直进展缓慢。我们认为，对临床医学生进行基于证据的MAT和丁丙诺啡实践培训，将消除阻碍临床医生开丁丙诺啡治疗OUD的培训和能力障碍。学生处于接受这种培训并从中受益的理想位置，并且能够影响医学界更好地治疗OUD。
